Ocular Therapeutix™ Reports Second Quarter 2019 Financial Results and Business Update
Commenced U.S. Launch of DEXTENZA® with Broad Reimbursement Status and Differentiated Product Label BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ:…